Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.406049676403928e-30,inf,inf,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.2227718338290102e-27,0,0,68
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.8355037194415667e-15,34.50617283950617,1155.837978286205,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",5.089729176397612e-13,0,0,40
3,Nonalcoholic fatty liver disease WP4396,6.337525728459203e-10,8.779141104294478,185.93661189803856,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'CYC1', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",7.583905788389512e-08,0,0,36
4,Oxidative phosphorylation WP623,5.4293780110430186e-08,18.465465465465467,308.90611576083376,"['NDUFB9', 'ATP5PF', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'ATP6AP2', 'ATP5MC2', 'NDUFB2', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",4.872866764911109e-06,0,0,22
5,Mitochondrial complex I assembly model OXPHOS system WP4324,4.642837765520634e-06,14.162444113263785,173.91743080695258,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",0.00028646334195351415,0,0,17
6,Mitochondrial CIV Assembly WP4922,4.787688166353997e-06,24.940564635958395,305.5085212270116,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'COX14', 'COX20']",0.00028646334195351415,0,0,15
7,Mitochondrial complex III assembly WP4921,0.0004286505747233161,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.02198365090366721,0,0,8
8,Amino Acid metabolism WP3925,0.0011336341990537703,inf,inf,"['LDHA', 'PKM', 'GOT1', 'MDH2', 'GSS', 'ODC1', 'SRM']",0.045219408606700394,0,0,7
9,Glycolysis and Gluconeogenesis WP534,0.0011336341990537703,inf,inf,"['LDHA', 'PKM', 'GOT1', 'MDH2', 'PGAM1', 'ALDOC', 'PFKM']",0.045219408606700394,0,0,7
10,Acute viral myocarditis WP4298,0.01834008922118313,5.745961820851688,22.97618186766745,"['ENDOG', 'CXADR', 'TGFB1', 'CASP6', 'CYCS', 'BAX', 'EIF4G2']",0.6584092030404743,0,0,7
11,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.020854761607843317,inf,inf,"['NDUFA13', 'HSP90AA1', 'RIPK2', 'AAMP']",0.68062358338325,0,0,4
12,DNA IR-double strand breaks and cellular response via ATM WP3959,0.03246660989354189,8.191800878477306,28.07775062398212,"['DCLRE1C', 'PCNA', 'KAT5', 'CDKN2A', 'BAX']",0.9712927459817948,0,0,5
13,Cellular Proteostasis WP4918,0.054953229880858795,inf,inf,"['VBP1', 'PFDN5', 'PFDN6']",0.9854814999105933,0,0,3
14,Computational Model of Aerobic Glycolysis WP4629,0.054953229880858795,inf,inf,"['LDHA', 'PKM', 'PFKM']",0.9854814999105933,0,0,3
15,Glycolysis in senescence WP5049,0.054953229880858795,inf,inf,"['LDHA', 'PKM', 'ALDOC']",0.9854814999105933,0,0,3
16,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.054953229880858795,inf,inf,"['FGF1', 'RUNX2', 'FGFR2']",0.9854814999105933,0,0,3
17,Nanomaterial induced apoptosis WP2507,0.07264505615712734,6.543859649122807,17.159112072828126,"['ENDOG', 'CASP6', 'BAX', 'CYCS']",0.9854814999105933,0,0,4
18,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.07821916291303772,4.0922401171303076,10.428012458120369,"['MAPK11', 'HSP90AA1', 'CCNE1', 'CDKN2A', 'BAX']",0.9854814999105933,0,0,5
19,Pancreatic adenocarcinoma pathway WP4263,0.07869038999844083,3.275659824046921,8.327494564300792,"['TGFB1', 'CDK6', 'CDKN2A', 'PRKCD', 'BAX', 'PLD1']",0.9854814999105933,0,0,6
20,VEGFA-VEGFR2 Signaling Pathway WP3888,0.1076084267214562,1.4705882352941178,3.278318116273182,"['SET', 'RPL10A', 'RPL7', 'SCUBE2', 'LDHA', 'RPL18A', 'TMSB4X', 'RPLP2', 'DNAJB9', 'ATP6V1E1', 'CCT7', 'HSP90AA1', 'SSR4', 'TRPC3', 'PRKCD', 'RPS6', 'RPL13A', 'RCN1', 'PTPN9', 'CYCS', 'RPL27', 'PRKD1', 'RPL26', 'EIF3D', 'EIF4G2']",0.9854814999105933,0,0,25
21,Modulators of TCR signaling and T cell activation WP5072,0.14448972595532966,2.7257198633479747,5.273032842709251,"['FIBP', 'NDUFB10', 'ELOB', 'LCP2', 'RNF7']",0.9854814999105933,0,0,5
22,Parkinson's disease pathway WP2371,0.14448972595532966,2.7257198633479747,5.273032842709251,"['MAPK11', 'CASP6', 'CCNE1', 'CYCS', 'PARK7']",0.9854814999105933,0,0,5
23,Serotonin and anxiety WP3947,0.1446731117058924,inf,inf,"['CRH', 'HTR2C']",0.9854814999105933,0,0,2
24,Serotonin and anxiety-related events WP3944,0.1446731117058924,inf,inf,"['CRH', 'HTR2C']",0.9854814999105933,0,0,2
25,Amyotrophic lateral sclerosis (ALS) WP2447,0.1446731117058924,inf,inf,"['TOMM40', 'BAX']",0.9854814999105933,0,0,2
26,Apoptosis Modulation by HSP70 WP384,0.1446731117058924,inf,inf,"['CASP6', 'CYCS']",0.9854814999105933,0,0,2
27,CAMKK2  Pathway WP4874,0.1446731117058924,inf,inf,"['FIS1', 'MAP1LC3A']",0.9854814999105933,0,0,2
28,Type II diabetes mellitus WP1584,0.1446731117058924,inf,inf,"['SURF1', 'PRKCD']",0.9854814999105933,0,0,2
29,Urea cycle and associated pathways WP4595,0.1446731117058924,inf,inf,"['GOT1', 'MDH2']",0.9854814999105933,0,0,2
30,Urea cycle and metabolism of amino groups WP497,0.1446731117058924,inf,inf,"['ODC1', 'SRM']",0.9854814999105933,0,0,2
31,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.1446731117058924,inf,inf,"['TGFB1', 'VIP']",0.9854814999105933,0,0,2
32,Cori Cycle WP1946,0.1446731117058924,inf,inf,"['LDHA', 'PGAM1']",0.9854814999105933,0,0,2
33,Wnt Signaling Pathway WP363,0.1446731117058924,inf,inf,"['CDK6', 'ROR2']",0.9854814999105933,0,0,2
34,Dual hijack model of Vif in HIV infection WP3300,0.1446731117058924,inf,inf,"['ELOB', 'RUNX1']",0.9854814999105933,0,0,2
35,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.1446731117058924,inf,inf,"['H3F3B', 'H2AFZ']",0.9854814999105933,0,0,2
36,Gastric acid production WP2596,0.1446731117058924,inf,inf,"['CCK', 'VIP']",0.9854814999105933,0,0,2
37,Glutathione metabolism WP100,0.1446731117058924,inf,inf,"['GPX4', 'GSS']",0.9854814999105933,0,0,2
38,Hematopoietic Stem Cell Differentiation WP2849,0.1446731117058924,inf,inf,"['PIM1', 'RUNX1']",0.9854814999105933,0,0,2
39,Histone Modifications WP2369,0.1446731117058924,inf,inf,"['SET', 'H3F3B']",0.9854814999105933,0,0,2
40,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.1446731117058924,inf,inf,"['SFRP1', 'TGFB1']",0.9854814999105933,0,0,2
41,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.1446731117058924,inf,inf,"['GOT1', 'MDH2']",0.9854814999105933,0,0,2
42,NO/cGMP/PKG mediated Neuroprotection WP4008,0.1446731117058924,inf,inf,"['PDE3A', 'CYCS']",0.9854814999105933,0,0,2
43,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.1446731117058924,inf,inf,"['TGFB1', 'BAX']",0.9854814999105933,0,0,2
44,16p11.2 proximal deletion syndrome WP4949,0.1530019819687912,3.2690058479532165,6.136919073852238,"['PCNA', 'ASPHD1', 'SEZ6L2', 'CCT7']",0.9854814999105933,0,0,4
45,Base Excision Repair WP4752,0.1530019819687912,3.2690058479532165,6.136919073852238,"['POLE4', 'PCNA', 'NEIL2', 'APEX1']",0.9854814999105933,0,0,4
46,Corticotropin-releasing hormone signaling pathway WP2355,0.1530019819687912,3.2690058479532165,6.136919073852238,"['HSP90AA1', 'TGFB1', 'PRKCD', 'CRH']",0.9854814999105933,0,0,4
47,Metabolic reprogramming in colon cancer WP4290,0.1530019819687912,3.2690058479532165,6.136919073852238,"['LDHA', 'PKM', 'MDH2', 'PGAM1']",0.9854814999105933,0,0,4
48,Prader-Willi and Angelman Syndrome WP3998,0.1530019819687912,3.2690058479532165,6.136919073852238,"['CDK6', 'CDKN2A', 'HTR2C', 'GABRD']",0.9854814999105933,0,0,4
49,Cardiac Hypertrophic Response WP2795,0.15724866303438767,4.9007299270072995,9.065992051053888,"['TGFB1', 'PRKD1', 'FGFR2']",0.9854814999105933,0,0,3
50,Type 2 papillary renal cell carcinoma WP4241,0.15724866303438767,4.9007299270072995,9.065992051053888,"['TGFB1', 'COL21A1', 'ELOB']",0.9854814999105933,0,0,3
51,Nucleotide metabolism WP404,0.15724866303438767,4.9007299270072995,9.065992051053888,"['NME2', 'OAZ1', 'SRM']",0.9854814999105933,0,0,3
52,Selenium Micronutrient Network WP15,0.18558075848421587,1.9084679393049437,3.2143660132771195,"['SELENOM', 'GPX4', 'SELENOS', 'SELENOW', 'SELENOK', 'SEPHS2', 'SELENOH']",0.9854814999105933,0,0,7
53,Apoptosis Modulation and Signaling WP1772,0.18558075848421587,1.9084679393049437,3.2143660132771195,"['HRK', 'ENDOG', 'CASP6', 'CDKN2A', 'CYCS', 'BAX', 'PRKD1']",0.9854814999105933,0,0,7
54,Cell cycle WP179,0.18558075848421587,1.9084679393049437,3.2143660132771195,"['TGFB1', 'CDK6', 'PCNA', 'CCNE1', 'CDKN2A', 'CDC14B', 'ANAPC11']",0.9854814999105933,0,0,7
55,Apoptosis WP254,0.2267389011028291,2.042459736456808,3.030920664396064,"['HRK', 'CASP6', 'CDKN2A', 'CYCS', 'BAX']",0.9854814999105933,0,0,5
56,miRNA regulation of DNA damage response WP1530,0.2267389011028291,2.042459736456808,3.030920664396064,"['CDK6', 'CCNE1', 'CCNG1', 'CYCS', 'BAX']",0.9854814999105933,0,0,5
57,Proteasome Degradation WP183,0.2267389011028291,2.042459736456808,3.030920664396064,"['PSMB6', 'PSMC5', 'H2AFZ', 'HLA-B', 'PSMB10']",0.9854814999105933,0,0,5
58,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.2527124045960481,2.1773879142300196,2.9950039948073592,"['CCNE1', 'APEX1', 'RPS6', 'PLD1']",0.9854814999105933,0,0,4
59,DNA Repair Pathways Full Network WP4946,0.2550576443476852,1.6343612334801763,2.232971699788587,"['FANCI', 'POLE4', 'DCLRE1C', 'NEIL2', 'PCNA', 'CENPX', 'APEX1']",0.9854814999105933,0,0,7
60,Gastrin signaling pathway WP4659,0.2840442829093094,1.6334310850439884,2.055877407249759,"['KAT5', 'CDKN2A', 'RPS6', 'PRKCD', 'KIT', 'PRKD1']",0.9854814999105933,0,0,6
61,Hepatitis B infection WP4666,0.2840442829093094,1.6334310850439884,2.055877407249759,"['MAPK11', 'TGFB1', 'PCNA', 'ATP6AP1', 'CYCS', 'BAX']",0.9854814999105933,0,0,6
62,TP53 network WP1742,0.284154048546983,2.448175182481752,3.080388914238177,"['SUMO1', 'CDKN2A', 'BAX']",0.9854814999105933,0,0,3
63,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.284154048546983,2.448175182481752,3.080388914238177,"['PRKCD', 'RPS6', 'PIM1']",0.9854814999105933,0,0,3
64,Tumor suppressor activity of SMARCB1 WP4204,0.284154048546983,2.448175182481752,3.080388914238177,"['CDK6', 'H3F3B', 'CDKN2A']",0.9854814999105933,0,0,3
65,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.284154048546983,2.448175182481752,3.080388914238177,"['MAP1LC3A', 'IGFBP5', 'PLD1']",0.9854814999105933,0,0,3
66,Glycosylation and related congenital defects WP4521,0.284154048546983,2.448175182481752,3.080388914238177,"['DPM2', 'DPM3', 'MAGT1']",0.9854814999105933,0,0,3
67,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.284154048546983,2.448175182481752,3.080388914238177,"['IFITM3', 'MAPK11', 'DDIT3']",0.9854814999105933,0,0,3
68,Interleukin-11 Signaling Pathway WP2332,0.284154048546983,2.448175182481752,3.080388914238177,"['TGFB1', 'RPS6', 'RUNX2']",0.9854814999105933,0,0,3
69,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.284154048546983,2.448175182481752,3.080388914238177,"['LDHA', 'PKM', 'BAX']",0.9854814999105933,0,0,3
70,Pregnane X receptor pathway WP2876,0.284154048546983,2.448175182481752,3.080388914238177,"['HSP90AA1', 'PSMC5', 'CYP3A5']",0.9854814999105933,0,0,3
71,Rett syndrome causing genes WP4312,0.284154048546983,2.448175182481752,3.080388914238177,"['IMPDH2', 'HAP1', 'GABRD']",0.9854814999105933,0,0,3
72,7q11.23 copy number variation syndrome WP4932,0.3185800267557905,1.6325036603221084,1.8673908567440713,"['PCNA', 'ATP5MC2', 'GTF2IRD1', 'ATP5F1E', 'ATP5MC1']",0.9854814999105933,0,0,5
73,Ferroptosis WP4313,0.3185800267557905,1.6325036603221084,1.8673908567440713,"['MAP1LC3A', 'GPX4', 'GSS', 'SAT2', 'FTL']",0.9854814999105933,0,0,5
74,Pathways in clear cell renal cell carcinoma WP4018,0.3185800267557905,1.6325036603221084,1.8673908567440713,"['LDHA', 'PKM', 'TGFB1', 'ALDOC', 'PFKM']",0.9854814999105933,0,0,5
75,ACE Inhibitor Pathway WP554,0.3241127660979174,3.262390670553936,3.6756174054760256,"['TGFB1', 'ATP6AP2']",0.9854814999105933,0,0,2
76,BMP Signaling Pathway in Eyelid Development WP3927,0.3241127660979174,3.262390670553936,3.6756174054760256,"['SFRP1', 'FGFR2']",0.9854814999105933,0,0,2
77,Type II interferon signaling (IFNG) WP619,0.3241127660979174,3.262390670553936,3.6756174054760256,"['PRKCD', 'HLA-B']",0.9854814999105933,0,0,2
78,Cysteine and methionine catabolism WP4504,0.3241127660979174,3.262390670553936,3.6756174054760256,"['GOT1', 'GSS']",0.9854814999105933,0,0,2
79,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.3241127660979174,3.262390670553936,3.6756174054760256,"['RPS6', 'SGK1']",0.9854814999105933,0,0,2
80,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.3241127660979174,3.262390670553936,3.6756174054760256,"['MAPK11', 'BAX']",0.9854814999105933,0,0,2
81,miRNAs involved in DNA damage response WP1545,0.3241127660979174,3.262390670553936,3.6756174054760256,"['CDK6', 'CCNE1']",0.9854814999105933,0,0,2
82,Neovascularisation processes WP4331,0.3241127660979174,3.262390670553936,3.6756174054760256,"['TGFB1', 'KIT']",0.9854814999105933,0,0,2
83,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.3241127660979174,3.262390670553936,3.6756174054760256,"['MAP1LC3A', 'FTL']",0.9854814999105933,0,0,2
84,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.3241127660979174,3.262390670553936,3.6756174054760256,"['EIF3I', 'EIF3D']",0.9854814999105933,0,0,2
85,Oxidation by Cytochrome P450 WP43,0.3241127660979174,3.262390670553936,3.6756174054760256,"['CYB5R1', 'CYP3A5']",0.9854814999105933,0,0,2
86,22q11.2 copy number variation syndrome WP4657,0.36093505248935653,1.631578947368421,1.6626723501021217,"['RANBP1', 'MRPL40', 'DGCR6L', 'FGFR2']",0.9854814999105933,0,0,4
87,DNA damage response WP707,0.36093505248935653,1.631578947368421,1.6626723501021217,"['CDK6', 'CCNE1', 'CYCS', 'BAX']",0.9854814999105933,0,0,4
88,Non-small cell lung cancer WP4255,0.36093505248935653,1.631578947368421,1.6626723501021217,"['CDK6', 'CDKN2A', 'CYCS', 'BAX']",0.9854814999105933,0,0,4
89,Osteoblast differentiation WP4787,0.36844156743666284,1.3988269794721409,1.3966911785667533,"['MAPK11', 'PRKCD', 'PRKD1', 'FGF1', 'RUNX2', 'FGFR2']",0.9854814999105933,0,0,6
90,MAPK Signaling Pathway WP382,0.3693889019048827,1.3058823529411765,1.3005350980183632,"['DUSP4', 'MAPK11', 'TGFB1', 'DDIT3', 'RASGRF2', 'PRKCD', 'FGF1', 'FGFR2']",0.9854814999105933,0,0,8
91,15q11.2 copy number variation syndrome WP4940,0.3805308040397569,inf,inf,['TUBGCP4'],0.9854814999105933,0,0,1
92,Selective expression of chemokine receptors during T-cell polarization WP4494,0.3805308040397569,inf,inf,['TGFB1'],0.9854814999105933,0,0,1
93,16p11.2 distal deletion syndrome WP4950,0.3805308040397569,inf,inf,['CD81'],0.9854814999105933,0,0,1
94,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.3805308040397569,inf,inf,['APOE'],0.9854814999105933,0,0,1
95,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.3805308040397569,inf,inf,['EPHX2'],0.9854814999105933,0,0,1
96,Tamoxifen metabolism WP691,0.3805308040397569,inf,inf,['CYP3A5'],0.9854814999105933,0,0,1
97,TCA cycle in senescence WP5050,0.3805308040397569,inf,inf,['GOT1'],0.9854814999105933,0,0,1
98,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.3805308040397569,inf,inf,['TGFB1'],0.9854814999105933,0,0,1
99,Biomarkers for urea cycle disorders WP4583,0.3805308040397569,inf,inf,['GOT1'],0.9854814999105933,0,0,1
100,Thiamine metabolic pathways WP4297,0.3805308040397569,inf,inf,['BCKDK'],0.9854814999105933,0,0,1
101,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.3805308040397569,inf,inf,['RUNX2'],0.9854814999105933,0,0,1
102,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.3805308040397569,inf,inf,['RPS6'],0.9854814999105933,0,0,1
103,Canonical and non-canonical TGF-B signaling WP3874,0.3805308040397569,inf,inf,['TGFB1'],0.9854814999105933,0,0,1
104,"Cerebral organic acidurias, including diseases WP4519",0.3805308040397569,inf,inf,['MDH2'],0.9854814999105933,0,0,1
105,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.3805308040397569,inf,inf,['RPH3AL'],0.9854814999105933,0,0,1
106,Ebstein-Barr virus LMP1 signaling WP262,0.3805308040397569,inf,inf,['HSP90AA1'],0.9854814999105933,0,0,1
107,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.3805308040397569,inf,inf,['H3F3B'],0.9854814999105933,0,0,1
108,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.3805308040397569,inf,inf,['EPHX2'],0.9854814999105933,0,0,1
109,EV release from cardiac cells and their functional effects WP3297,0.3805308040397569,inf,inf,['RGS16'],0.9854814999105933,0,0,1
110,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.3805308040397569,inf,inf,['GSS'],0.9854814999105933,0,0,1
111,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.3805308040397569,inf,inf,['GABBR1'],0.9854814999105933,0,0,1
112,HIF1A and PPARG regulation of glycolysis WP2456,0.3805308040397569,inf,inf,['LDHA'],0.9854814999105933,0,0,1
113,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.3805308040397569,inf,inf,['ELOB'],0.9854814999105933,0,0,1
114,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.3805308040397569,inf,inf,['MAP1LC3A'],0.9854814999105933,0,0,1
115,Insulin signaling in adipocytes (diabetic condition) WP3635,0.3805308040397569,inf,inf,['RPS6'],0.9854814999105933,0,0,1
116,Insulin signaling in adipocytes (normal condition) WP3634,0.3805308040397569,inf,inf,['RPS6'],0.9854814999105933,0,0,1
117,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.3805308040397569,inf,inf,['TGFB1'],0.9854814999105933,0,0,1
118,Irinotecan pathway WP229,0.3805308040397569,inf,inf,['CYP3A5'],0.9854814999105933,0,0,1
119,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.3805308040397569,inf,inf,['ACOT2'],0.9854814999105933,0,0,1
120,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.3805308040397569,inf,inf,['GABRD'],0.9854814999105933,0,0,1
121,Metastatic brain tumor WP2249,0.3805308040397569,inf,inf,['CDK6'],0.9854814999105933,0,0,1
122,Mitochondrial fatty acid synthesis pathway WP4317,0.3805308040397569,inf,inf,['HSD17B12'],0.9854814999105933,0,0,1
123,NAD+ metabolism WP3644,0.3805308040397569,inf,inf,['NMNAT1'],0.9854814999105933,0,0,1
124,Nanoparticle triggered autophagic cell death WP2509,0.3805308040397569,inf,inf,['MAP1LC3A'],0.9854814999105933,0,0,1
125,Nanoparticle triggered regulated necrosis WP2513,0.3805308040397569,inf,inf,['FTL'],0.9854814999105933,0,0,1
126,Non-homologous end joining WP438,0.3805308040397569,inf,inf,['DCLRE1C'],0.9854814999105933,0,0,1
127,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.3805308040397569,inf,inf,['MAPK11'],0.9854814999105933,0,0,1
128,Omega-3/Omega-6 FA synthesis WP4723,0.3805308040397569,inf,inf,['ACOT2'],0.9854814999105933,0,0,1
129,Peroxiredoxin 2 induced ovarian failure WP4873,0.3805308040397569,inf,inf,['BAX'],0.9854814999105933,0,0,1
130,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.3805308040397569,inf,inf,['LDHA'],0.9854814999105933,0,0,1
131,Platelet-mediated interactions with vascular and circulating cells WP4462,0.3805308040397569,inf,inf,['TGFB1'],0.9854814999105933,0,0,1
132,Role of Osx and miRNAs in tooth development WP3971,0.3805308040397569,inf,inf,['RUNX2'],0.9854814999105933,0,0,1
133,Glioblastoma signaling pathways WP2261,0.4135029640661317,1.3591996095656418,1.2002963937112423,"['CDK6', 'CCNE1', 'CDKN2A', 'PRKCD', 'FGFR2']",0.9854814999105933,0,0,5
134,Alzheimer's disease WP2059,0.4153060570368242,1.6306569343065693,1.4329227304253855,"['ATP5MD', 'CYCS', 'APOE']",0.9854814999105933,0,0,3
135,Differentiation Pathway WP2848,0.4153060570368242,1.6306569343065693,1.4329227304253855,"['TGFB1', 'KIT', 'FGF1']",0.9854814999105933,0,0,3
136,Fas ligand pathway and stress induction of heat shock proteins WP314,0.4153060570368242,1.6306569343065693,1.4329227304253855,"['CASP6', 'RIPK2', 'CYCS']",0.9854814999105933,0,0,3
137,GABA receptor Signaling WP4159,0.4153060570368242,1.6306569343065693,1.4329227304253855,"['GABBR1', 'SLC32A1', 'GABRD']",0.9854814999105933,0,0,3
138,One-carbon metabolism and related pathways WP3940,0.4153060570368242,1.6306569343065693,1.4329227304253855,"['GPX4', 'GSS', 'PLD1']",0.9854814999105933,0,0,3
139,Ciliary landscape WP4352,0.44186130416301367,1.186096256684492,0.9687550743697912,"['VPS4A', 'CD2BP2', 'COPS7A', 'MYL6B', 'WDR34', 'COX6C', 'DCAF11', 'LSM4']",0.9854814999105933,0,0,8
140,IL-18 signaling pathway WP4754,0.4473123549563935,1.1160233918128655,0.8978387515468752,"['TOMM40', 'USP5', 'CD81', 'RGS16', 'PRKCD', 'COX17', 'NDUFC1', 'PLD1', 'RUNX2', 'TMSB4X', 'SYT10', 'CYCS', 'BAX']",0.9854814999105933,0,0,13
141,Androgen receptor signaling pathway WP138,0.45347947534266747,1.2228739002932552,0.967055123419456,"['SUMO1', 'KAT5', 'CCNE1', 'STUB1', 'PARK7', 'RUNX2']",0.9854814999105933,0,0,6
142,Small cell lung cancer WP4658,0.4682919228276363,1.304093567251462,0.9893680737338212,"['CDK6', 'CCNE1', 'CYCS', 'BAX']",0.9854814999105933,0,0,4
143,Aryl Hydrocarbon Receptor Pathway WP2873,0.4682919228276363,1.304093567251462,0.9893680737338212,"['HSP90AA1', 'TGFB1', 'AIP', 'BAX']",0.9854814999105933,0,0,4
144,T-cell receptor (TCR) signaling pathway WP69,0.4682919228276363,1.304093567251462,0.9893680737338212,"['TGFB1', 'RIPK2', 'PRKCD', 'LCP2']",0.9854814999105933,0,0,4
145,G1 to S cell cycle control WP45,0.4682919228276363,1.304093567251462,0.9893680737338212,"['PCNA', 'CDK6', 'CCNE1', 'CDKN2A']",0.9854814999105933,0,0,4
146,Melanoma WP4685,0.4682919228276363,1.304093567251462,0.9893680737338212,"['CDK6', 'CDKN2A', 'KIT', 'BAX']",0.9854814999105933,0,0,4
147,Retinoblastoma gene in cancer WP2446,0.4682919228276363,1.304093567251462,0.9893680737338212,"['PCNA', 'CDK6', 'H2AFZ', 'CCNE1']",0.9854814999105933,0,0,4
148,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.49097674661130836,1.629737609329446,1.1593277199943306,"['TGFB1', 'RUNX2']",0.9854814999105933,0,0,2
149,Constitutive Androstane Receptor Pathway WP2875,0.49097674661130836,1.629737609329446,1.1593277199943306,"['HSP90AA1', 'CYP3A5']",0.9854814999105933,0,0,2
150,Cytosolic DNA-sensing pathway WP4655,0.49097674661130836,1.629737609329446,1.1593277199943306,"['POLR2K', 'POLR2L']",0.9854814999105933,0,0,2
151,Mammalian disorder of sexual development WP4842,0.49097674661130836,1.629737609329446,1.1593277199943306,"['MAPK11', 'FGFR2']",0.9854814999105933,0,0,2
152,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.49097674661130836,1.629737609329446,1.1593277199943306,"['MAPK11', 'FGFR2']",0.9854814999105933,0,0,2
153,Methionine De Novo and Salvage Pathway WP3580,0.49097674661130836,1.629737609329446,1.1593277199943306,"['ODC1', 'SRM']",0.9854814999105933,0,0,2
154,Oxidative Damage WP3941,0.49097674661130836,1.629737609329446,1.1593277199943306,"['PCNA', 'CYCS']",0.9854814999105933,0,0,2
155,Ectoderm Differentiation WP2858,0.5059734033383034,1.16398243045388,0.7929876765017284,"['PIM1', 'ROR2', 'NR2F2', 'JAKMIP1', 'FGFR2']",0.9854814999105933,0,0,5
156,Pyrimidine metabolism WP4022,0.535473163598654,1.086021505376344,0.6783339247977891,"['POLE4', 'NME2', 'NME3', 'POLR2I', 'POLR2K', 'POLR2L']",0.9854814999105933,0,0,6
157,Synaptic Vesicle Pathway WP2267,0.5372512183378014,1.2218978102189781,0.7591522499094567,"['SLC32A1', 'PARK7', 'CPLX3']",0.9854814999105933,0,0,3
158,Translation Factors WP107,0.5372512183378014,1.2218978102189781,0.7591522499094567,"['EEF1B2', 'EIF3I', 'EIF3D']",0.9854814999105933,0,0,3
159,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.5372512183378014,1.2218978102189781,0.7591522499094567,"['MAPK11', 'BAX', 'ANGPTL1']",0.9854814999105933,0,0,3
160,Regulation of toll-like receptor signaling pathway WP1449,0.5372512183378014,1.2218978102189781,0.7591522499094567,"['MAPK11', 'CUEDC2', 'PELI3']",0.9854814999105933,0,0,3
161,Endoderm differentiation WP2853,0.5680997886034053,1.0857699805068226,0.6139575295957285,"['DUSP4', 'SFRP1', 'TGFB1', 'TCEAL2']",0.9854814999105933,0,0,4
162,Metapathway biotransformation Phase I and II WP702,0.5680997886034053,1.0857699805068226,0.6139575295957285,"['GPX4', 'EPHX2', 'GSS', 'CYP3A5']",0.9854814999105933,0,0,4
163,Proximal tubule transport WP4917,0.5680997886034053,1.0857699805068226,0.6139575295957285,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.9854814999105933,0,0,4
164,EGF/EGFR signaling pathway WP437,0.5919307430752131,1.0175695461200585,0.5335785052684091,"['NDUFA13', 'PCNA', 'PRKCD', 'NEDD8', 'PLD1']",0.9854814999105933,0,0,5
165,mRNA Processing WP411,0.5919307430752131,1.0175695461200585,0.5335785052684091,"['SF3B5', 'LSM7', 'SF3A1', 'CD2BP2', 'SRSF9']",0.9854814999105933,0,0,5
166,Vitamin D Receptor Pathway WP2877,0.6116820120720172,0.9765395894428153,0.48001092561142916,"['SFRP1', 'TGFB1', 'IGFBP5', 'CCNE1', 'CDKN2A', 'CYP3A5']",0.9854814999105933,0,0,6
167,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.6163881925158899,1.6288209606986899,0.7881511684080696,['HTR2C'],0.9854814999105933,0,0,1
168,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.6163881925158899,1.6288209606986899,0.7881511684080696,['MAPK11'],0.9854814999105933,0,0,1
169,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.6163881925158899,1.6288209606986899,0.7881511684080696,['LCP2'],0.9854814999105933,0,0,1
170,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.6163881925158899,1.6288209606986899,0.7881511684080696,['MDH2'],0.9854814999105933,0,0,1
171,Trans-sulfuration and one-carbon metabolism WP2525,0.6163881925158899,1.6288209606986899,0.7881511684080696,['GSS'],0.9854814999105933,0,0,1
172,Trans-sulfuration pathway WP2333,0.6163881925158899,1.6288209606986899,0.7881511684080696,['GOT1'],0.9854814999105933,0,0,1
173,Transcription co-factors SKI and SKIL protein partners WP4533,0.6163881925158899,1.6288209606986899,0.7881511684080696,['MERTK'],0.9854814999105933,0,0,1
174,Transcriptional cascade regulating adipogenesis WP4211,0.6163881925158899,1.6288209606986899,0.7881511684080696,['DDIT3'],0.9854814999105933,0,0,1
175,Cell Differentiation - Index expanded WP2023,0.6163881925158899,1.6288209606986899,0.7881511684080696,['RUNX2'],0.9854814999105933,0,0,1
176,Tryptophan catabolism leading to NAD+ production WP4210,0.6163881925158899,1.6288209606986899,0.7881511684080696,['NMNAT1'],0.9854814999105933,0,0,1
177,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.6163881925158899,1.6288209606986899,0.7881511684080696,['CCK'],0.9854814999105933,0,0,1
178,Composition of Lipid Particles WP3601,0.6163881925158899,1.6288209606986899,0.7881511684080696,['APOE'],0.9854814999105933,0,0,1
179,Cytokines and Inflammatory Response WP530,0.6163881925158899,1.6288209606986899,0.7881511684080696,['TGFB1'],0.9854814999105933,0,0,1
180,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.6163881925158899,1.6288209606986899,0.7881511684080696,['RUNX2'],0.9854814999105933,0,0,1
181,Dopaminergic Neurogenesis WP2855,0.6163881925158899,1.6288209606986899,0.7881511684080696,['TGFB1'],0.9854814999105933,0,0,1
182,Gastric Cancer Network 2 WP2363,0.6163881925158899,1.6288209606986899,0.7881511684080696,['FANCI'],0.9854814999105933,0,0,1
183,Globo Sphingolipid Metabolism WP1424,0.6163881925158899,1.6288209606986899,0.7881511684080696,['ST6GAL1'],0.9854814999105933,0,0,1
184,Glycerolipids and Glycerophospholipids WP4722,0.6163881925158899,1.6288209606986899,0.7881511684080696,['PLD1'],0.9854814999105933,0,0,1
185,Heart Development WP1591,0.6163881925158899,1.6288209606986899,0.7881511684080696,['VEGFB'],0.9854814999105933,0,0,1
186,ID signaling pathway WP53,0.6163881925158899,1.6288209606986899,0.7881511684080696,['CCNE1'],0.9854814999105933,0,0,1
187,Interferon type I signaling pathways WP585,0.6163881925158899,1.6288209606986899,0.7881511684080696,['RPS6'],0.9854814999105933,0,0,1
188,Intraflagellar transport proteins binding to dynein WP4532,0.6163881925158899,1.6288209606986899,0.7881511684080696,['WDR34'],0.9854814999105933,0,0,1
189,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.6163881925158899,1.6288209606986899,0.7881511684080696,['BAX'],0.9854814999105933,0,0,1
190,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.6163881925158899,1.6288209606986899,0.7881511684080696,['APOE'],0.9854814999105933,0,0,1
191,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.6163881925158899,1.6288209606986899,0.7881511684080696,['VEGFB'],0.9854814999105933,0,0,1
192,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6163881925158899,1.6288209606986899,0.7881511684080696,['BAX'],0.9854814999105933,0,0,1
193,MTHFR deficiency WP4288,0.6163881925158899,1.6288209606986899,0.7881511684080696,['CYCS'],0.9854814999105933,0,0,1
194,NAD Biosynthesis II (from tryptophan) WP2485,0.6163881925158899,1.6288209606986899,0.7881511684080696,['NMNAT1'],0.9854814999105933,0,0,1
195,NAD+ biosynthetic pathways WP3645,0.6163881925158899,1.6288209606986899,0.7881511684080696,['NMNAT1'],0.9854814999105933,0,0,1
196,Neural Crest Cell Migration during Development WP4564,0.6163881925158899,1.6288209606986899,0.7881511684080696,['EPHB3'],0.9854814999105933,0,0,1
197,Neural Crest Cell Migration in Cancer WP4565,0.6163881925158899,1.6288209606986899,0.7881511684080696,['EPHB3'],0.9854814999105933,0,0,1
198,Osteoclast Signaling WP12,0.6163881925158899,1.6288209606986899,0.7881511684080696,['ATP6V1G1'],0.9854814999105933,0,0,1
199,Overview of nanoparticle effects WP3287,0.6163881925158899,1.6288209606986899,0.7881511684080696,['BAX'],0.9854814999105933,0,0,1
200,PKC-gamma calcium signaling pathway in ataxia WP4760,0.6163881925158899,1.6288209606986899,0.7881511684080696,['TRPC3'],0.9854814999105933,0,0,1
201,Purinergic signaling WP4900,0.6163881925158899,1.6288209606986899,0.7881511684080696,['P2RY14'],0.9854814999105933,0,0,1
202,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.6163881925158899,1.6288209606986899,0.7881511684080696,['ANAPC11'],0.9854814999105933,0,0,1
203,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.6163881925158899,1.6288209606986899,0.7881511684080696,['TGFB1'],0.9854814999105933,0,0,1
204,SARS-CoV-2 mitochondrial interactions WP5038,0.6163881925158899,1.6288209606986899,0.7881511684080696,['NDUFB9'],0.9854814999105933,0,0,1
205,3q29 copy number variation syndrome WP4906,0.6288584183895224,1.0855199222546161,0.5035174798060608,"['TGFB1', 'WDR34']",0.9854814999105933,0,0,2
206,7-oxo-C and 7beta-HC pathways WP5064,0.6288584183895224,1.0855199222546161,0.5035174798060608,"['EPHX2', 'ACOT2']",0.9854814999105933,0,0,2
207,AGE/RAGE pathway WP2324,0.6288584183895224,1.0855199222546161,0.5035174798060608,"['PRKCD', 'CYCS']",0.9854814999105933,0,0,2
208,ATM Signaling Network in Development and Disease  WP3878,0.6288584183895224,1.0855199222546161,0.5035174798060608,"['DCLRE1C', 'KAT5']",0.9854814999105933,0,0,2
209,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.6288584183895224,1.0855199222546161,0.5035174798060608,"['SFRP1', 'SST']",0.9854814999105933,0,0,2
210,TNF-alpha signaling pathway WP231,0.6288584183895224,1.0855199222546161,0.5035174798060608,"['HSP90AA1', 'BAX']",0.9854814999105933,0,0,2
211,Complement system WP2806,0.6288584183895224,1.0855199222546161,0.5035174798060608,"['RPS19', 'CD59']",0.9854814999105933,0,0,2
212,Copper homeostasis WP3286,0.6288584183895224,1.0855199222546161,0.5035174798060608,"['COX17', 'ATOX1']",0.9854814999105933,0,0,2
213,Zinc homeostasis WP3529,0.6288584183895224,1.0855199222546161,0.5035174798060608,"['SLC39A11', 'SLC39A7']",0.9854814999105933,0,0,2
214,DNA Mismatch Repair WP531,0.6288584183895224,1.0855199222546161,0.5035174798060608,"['POLE4', 'PCNA']",0.9854814999105933,0,0,2
215,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.6288584183895224,1.0855199222546161,0.5035174798060608,"['LDHA', 'RPS6']",0.9854814999105933,0,0,2
216,Kit receptor signaling pathway WP304,0.6288584183895224,1.0855199222546161,0.5035174798060608,"['RPS6', 'KIT']",0.9854814999105933,0,0,2
217,Cardiac Progenitor Differentiation WP2406,0.64304082736528,0.9766423357664233,0.4312335536263936,"['TGFB1', 'KIT', 'ROR2']",0.9854814999105933,0,0,3
218,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.64304082736528,0.9766423357664233,0.4312335536263936,"['TGFB1', 'CYCS', 'BAX']",0.9854814999105933,0,0,3
219,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.64304082736528,0.9766423357664233,0.4312335536263936,"['PPP1R14A', 'MAP1LC3A', 'DDIT3']",0.9854814999105933,0,0,3
220,Eukaryotic Transcription Initiation WP405,0.64304082736528,0.9766423357664233,0.4312335536263936,"['TAF13', 'POLR2I', 'POLR2K']",0.9854814999105933,0,0,3
221,MECP2 and Associated Rett Syndrome WP3584,0.64304082736528,0.9766423357664233,0.4312335536263936,"['SST', 'RPS6', 'SGK1']",0.9854814999105933,0,0,3
222,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.64304082736528,0.9766423357664233,0.4312335536263936,"['IFI27L2', 'MAPK11', 'PRKCD']",0.9854814999105933,0,0,3
223,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.6564407562394807,0.9298245614035088,0.39138438684946536,"['BEX3', 'RIPK2', 'RNF7', 'APOE']",0.9854814999105933,0,0,4
224,TGF-beta Signaling Pathway WP366,0.6564407562394807,0.9298245614035088,0.39138438684946536,"['TGFB1', 'PARD6A', 'SUMO1', 'RUNX2']",0.9854814999105933,0,0,4
225,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6564407562394807,0.9298245614035088,0.39138438684946536,"['RPS6', 'PDGFC', 'BAX', 'FGFR2']",0.9854814999105933,0,0,4
226,Head and Neck Squamous Cell Carcinoma WP4674,0.6564407562394807,0.9298245614035088,0.39138438684946536,"['CDK6', 'CDKN2A', 'RPS6', 'FGFR2']",0.9854814999105933,0,0,4
227,Allograft Rejection WP2328,0.7304151814080462,0.8131386861313868,0.255441147190356,"['TGFB1', 'COL5A1', 'HLA-B']",0.9854814999105933,0,0,3
228,Endometrial cancer WP4155,0.7304151814080462,0.8131386861313868,0.255441147190356,"['BAX', 'FGF1', 'FGFR2']",0.9854814999105933,0,0,3
229,Exercise-induced Circadian Regulation WP410,0.7304151814080462,0.8131386861313868,0.255441147190356,"['DAZAP2', 'SUMO1', 'EIF4G2']",0.9854814999105933,0,0,3
230,Hippo-Merlin Signaling Dysregulation WP4541,0.7304151814080462,0.8131386861313868,0.255441147190356,"['PPP1R14A', 'KIT', 'FGFR2']",0.9854814999105933,0,0,3
231,Pathways Regulating Hippo Signaling WP4540,0.7304151814080462,0.8131386861313868,0.255441147190356,"['PRKCD', 'KIT', 'FGFR2']",0.9854814999105933,0,0,3
232,Spinal Cord Injury WP2431,0.7316743508653003,0.8128654970760234,0.253955227149471,"['TGFB1', 'APEX1', 'CCNG1', 'OMG']",0.9854814999105933,0,0,4
233,Myometrial relaxation and contraction pathways WP289,0.7355354197635822,0.8125915080527086,0.2495928307492011,"['IGFBP5', 'RGS16', 'PRKCD', 'CRH', 'PRKD1']",0.9854814999105933,0,0,5
234,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.7356344692014707,0.8134110787172012,0.24973503823728183,"['TGFB1', 'RUNX2']",0.9854814999105933,0,0,2
235,TGF-beta Receptor Signaling WP560,0.7356344692014707,0.8134110787172012,0.24973503823728183,"['TGFB1', 'RUNX2']",0.9854814999105933,0,0,2
236,The influence of laminopathies on Wnt signaling WP4844,0.7356344692014707,0.8134110787172012,0.24973503823728183,"['CDK6', 'RUNX2']",0.9854814999105933,0,0,2
237,White fat cell differentiation WP4149,0.7356344692014707,0.8134110787172012,0.24973503823728183,"['DDIT3', 'NR2F2']",0.9854814999105933,0,0,2
238,Genotoxicity pathway WP4286,0.7356344692014707,0.8134110787172012,0.24973503823728183,"['RPS27', 'PHLDA3']",0.9854814999105933,0,0,2
239,IL-6 signaling pathway WP364,0.7356344692014707,0.8134110787172012,0.24973503823728183,"['PRKCD', 'VIP']",0.9854814999105933,0,0,2
240,Imatinib and Chronic Myeloid Leukemia WP3640,0.7356344692014707,0.8134110787172012,0.24973503823728183,"['KIT', 'PIM1']",0.9854814999105933,0,0,2
241,Lung fibrosis WP3624,0.7356344692014707,0.8134110787172012,0.24973503823728183,"['TGFB1', 'FGF1']",0.9854814999105933,0,0,2
242,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.7356344692014707,0.8134110787172012,0.24973503823728183,"['TGFB1', 'FGFR2']",0.9854814999105933,0,0,2
243,Nucleotide Excision Repair WP4753,0.7356344692014707,0.8134110787172012,0.24973503823728183,"['POLE4', 'PCNA']",0.9854814999105933,0,0,2
244,Oxysterols derived from cholesterol WP4545,0.7356344692014707,0.8134110787172012,0.24973503823728183,"['EPHX2', 'ACOT2']",0.9854814999105933,0,0,2
245,p53 transcriptional gene network WP4963,0.7356344692014707,0.8134110787172012,0.24973503823728183,"['CCNG1', 'BAX']",0.9854814999105933,0,0,2
246,Peptide GPCRs WP24,0.7356344692014707,0.8134110787172012,0.24973503823728183,"['MC1R', 'ACKR1']",0.9854814999105933,0,0,2
247,Signal transduction through IL1R WP4496,0.7625256783771893,0.8136826783114993,0.220604910960141,['TGFB1'],0.9854814999105933,0,0,1
248,Airway smooth muscle cell contraction WP4962,0.7625256783771893,0.8136826783114993,0.220604910960141,['PPP1R14A'],0.9854814999105933,0,0,1
249,Alanine and aspartate metabolism WP106,0.7625256783771893,0.8136826783114993,0.220604910960141,['GOT1'],0.9854814999105933,0,0,1
250,Alpha 6 Beta 4 signaling pathway WP244,0.7625256783771893,0.8136826783114993,0.220604910960141,['PRKCD'],0.9854814999105933,0,0,1
251,Splicing factor NOVA regulated synaptic proteins WP4148,0.7625256783771893,0.8136826783114993,0.220604910960141,['NTNG1'],0.9854814999105933,0,0,1
252,ATM Signaling Pathway WP2516,0.7625256783771893,0.8136826783114993,0.220604910960141,['CCNE1'],0.9854814999105933,0,0,1
253,Cannabinoid receptor signaling WP3869,0.7625256783771893,0.8136826783114993,0.220604910960141,['MAPK11'],0.9854814999105933,0,0,1
254,Cell migration and invasion through p75NTR WP4561,0.7625256783771893,0.8136826783114993,0.220604910960141,['EFNB3'],0.9854814999105933,0,0,1
255,Vitamin B12 metabolism WP1533,0.7625256783771893,0.8136826783114993,0.220604910960141,['APOE'],0.9854814999105933,0,0,1
256,Vitamin D-sensitive calcium signaling in depression WP4698,0.7625256783771893,0.8136826783114993,0.220604910960141,['GPX4'],0.9854814999105933,0,0,1
257,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.7625256783771893,0.8136826783114993,0.220604910960141,['FGFR2'],0.9854814999105933,0,0,1
258,Galanin receptor pathway WP4970,0.7625256783771893,0.8136826783114993,0.220604910960141,['PRKCD'],0.9854814999105933,0,0,1
259,Genes related to primary cilium development (based on CRISPR) WP4536,0.7625256783771893,0.8136826783114993,0.220604910960141,['WDR34'],0.9854814999105933,0,0,1
260,Genes targeted by miRNAs in adipocytes WP1992,0.7625256783771893,0.8136826783114993,0.220604910960141,['TMSB4X'],0.9854814999105933,0,0,1
261,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7625256783771893,0.8136826783114993,0.220604910960141,['TGFB1'],0.9854814999105933,0,0,1
262,IL-5 signaling pathway WP127,0.7625256783771893,0.8136826783114993,0.220604910960141,['RPS6'],0.9854814999105933,0,0,1
263,Joubert Syndrome WP4656,0.7625256783771893,0.8136826783114993,0.220604910960141,['KAT5'],0.9854814999105933,0,0,1
264,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7625256783771893,0.8136826783114993,0.220604910960141,['PRKCD'],0.9854814999105933,0,0,1
265,Matrix Metalloproteinases WP129,0.7625256783771893,0.8136826783114993,0.220604910960141,['MMP16'],0.9854814999105933,0,0,1
266,Melatonin metabolism and effects WP3298,0.7625256783771893,0.8136826783114993,0.220604910960141,['APOE'],0.9854814999105933,0,0,1
267,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.7625256783771893,0.8136826783114993,0.220604910960141,['B3GALT2'],0.9854814999105933,0,0,1
268,Nuclear receptors WP170,0.7625256783771893,0.8136826783114993,0.220604910960141,['NR2F2'],0.9854814999105933,0,0,1
269,Omega-9 FA synthesis WP4724,0.7625256783771893,0.8136826783114993,0.220604910960141,['ACOT2'],0.9854814999105933,0,0,1
270,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.7625256783771893,0.8136826783114993,0.220604910960141,['MAPK11'],0.9854814999105933,0,0,1
271,Pre-implantation embryo WP3527,0.7625256783771893,0.8136826783114993,0.220604910960141,['DDIT3'],0.9854814999105933,0,0,1
272,Prolactin Signaling Pathway WP2037,0.7625256783771893,0.8136826783114993,0.220604910960141,['RPS6'],0.9854814999105933,0,0,1
273,PI3K-Akt signaling pathway WP4172,0.7637384805754468,0.8112094395280236,0.2186451596305198,"['HSP90AA1', 'CDK6', 'CCNE1', 'PDGFC', 'KIT', 'RPS6', 'VEGFB', 'SGK1', 'FGF1', 'FGFR2']",0.9854814999105933,0,0,10
274,Ras signaling WP4223,0.7937825347555151,0.7218973359324237,0.16671911513449428,"['RASGRF2', 'KIT', 'PLD1', 'FGFR2']",0.9854814999105933,0,0,4
275,Senescence and Autophagy in Cancer WP615,0.7939220863247755,0.7572197748409202,0.17474357003664803,"['GABARAPL1', 'TGFB1', 'MAP1LC3A', 'PCNA', 'IGFBP5', 'CDKN2A', 'GABARAP']",0.9854814999105933,0,0,7
276,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.7999788184312538,0.6963503649635037,0.15540453088239625,"['SFRP1', 'CDK6', 'ROR2']",0.9854814999105933,0,0,3
277,Aryl Hydrocarbon Receptor Netpath WP2586,0.8149876383120102,0.6501457725947521,0.13300833931916486,"['HSP90AA1', 'AIP']",0.9854814999105933,0,0,2
278,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.8149876383120102,0.6501457725947521,0.13300833931916486,"['TGFB1', 'RUNX2']",0.9854814999105933,0,0,2
279,Thermogenesis WP4321,0.8149876383120102,0.6501457725947521,0.13300833931916486,"['MAPK11', 'RPS6']",0.9854814999105933,0,0,2
280,DNA IR-damage and cellular response via ATR WP4016,0.8149876383120102,0.6501457725947521,0.13300833931916486,"['FANCI', 'PCNA']",0.9854814999105933,0,0,2
281,Fragile X Syndrome  WP4549,0.8149876383120102,0.6501457725947521,0.13300833931916486,"['CDKN2A', 'GABRD']",0.9854814999105933,0,0,2
282,Leptin signaling pathway WP2034,0.8149876383120102,0.6501457725947521,0.13300833931916486,"['RPS6', 'BAX']",0.9854814999105933,0,0,2
283,Photodynamic therapy-induced unfolded protein response WP3613,0.8149876383120102,0.6501457725947521,0.13300833931916486,"['DDIT3', 'DNAJB9']",0.9854814999105933,0,0,2
284,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.8530417908379707,0.5419699175157691,0.08614435152086994,['TGFB1'],0.9854814999105933,0,0,1
285,Sleep regulation WP3591,0.8530417908379707,0.5419699175157691,0.08614435152086994,['CRH'],0.9854814999105933,0,0,1
286,Angiogenesis WP1539,0.8530417908379707,0.5419699175157691,0.08614435152086994,['FGFR2'],0.9854814999105933,0,0,1
287,Target Of Rapamycin (TOR) Signaling WP1471,0.8530417908379707,0.5419699175157691,0.08614435152086994,['RRAGA'],0.9854814999105933,0,0,1
288,BDNF-TrkB Signaling WP3676,0.8530417908379707,0.5419699175157691,0.08614435152086994,['TRPC3'],0.9854814999105933,0,0,1
289,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8530417908379707,0.5419699175157691,0.08614435152086994,['RPS6'],0.9854814999105933,0,0,1
290,Toll-like Receptor Signaling Pathway WP75,0.8530417908379707,0.5419699175157691,0.08614435152086994,['MAPK11'],0.9854814999105933,0,0,1
291,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8530417908379707,0.5419699175157691,0.08614435152086994,['TGFB1'],0.9854814999105933,0,0,1
292,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.8530417908379707,0.5419699175157691,0.08614435152086994,['CD81'],0.9854814999105933,0,0,1
293,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.8530417908379707,0.5419699175157691,0.08614435152086994,['MAPK11'],0.9854814999105933,0,0,1
294,Gastric Cancer Network 1 WP2361,0.8530417908379707,0.5419699175157691,0.08614435152086994,['SMOC2'],0.9854814999105933,0,0,1
295,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.8530417908379707,0.5419699175157691,0.08614435152086994,['RUNX2'],0.9854814999105933,0,0,1
296,IL-2 signaling pathway WP49,0.8530417908379707,0.5419699175157691,0.08614435152086994,['RPS6'],0.9854814999105933,0,0,1
297,IL-3 signaling pathway WP286,0.8530417908379707,0.5419699175157691,0.08614435152086994,['TGFB1'],0.9854814999105933,0,0,1
298,IL-4 signaling pathway WP395,0.8530417908379707,0.5419699175157691,0.08614435152086994,['MAPK11'],0.9854814999105933,0,0,1
299,Integrated Cancer Pathway WP1971,0.8530417908379707,0.5419699175157691,0.08614435152086994,['BAX'],0.9854814999105933,0,0,1
300,miR-509-3p alteration of YAP1/ECM axis WP3967,0.8530417908379707,0.5419699175157691,0.08614435152086994,['COL5A1'],0.9854814999105933,0,0,1
301,Nanoparticle-mediated activation of receptor signaling WP2643,0.8530417908379707,0.5419699175157691,0.08614435152086994,['MAPK11'],0.9854814999105933,0,0,1
302,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.8530417908379707,0.5419699175157691,0.08614435152086994,['OMG'],0.9854814999105933,0,0,1
303,Ovarian infertility WP34,0.8530417908379707,0.5419699175157691,0.08614435152086994,['INHA'],0.9854814999105933,0,0,1
304,Physiological and pathological hypertrophy of the heart WP1528,0.8530417908379707,0.5419699175157691,0.08614435152086994,['MAPK11'],0.9854814999105933,0,0,1
305,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8530417908379707,0.5419699175157691,0.08614435152086994,['BAX'],0.9854814999105933,0,0,1
306,Regulation of Microtubule Cytoskeleton WP2038,0.8530417908379707,0.5419699175157691,0.08614435152086994,['PARD6A'],0.9854814999105933,0,0,1
307,DNA damage response (only ATM dependent) WP710,0.8538054871487499,0.6087591240875913,0.0962155227758276,"['TGFB1', 'CDKN2A', 'BAX']",0.9854814999105933,0,0,3
308,Ebola Virus Pathway on Host WP4217,0.8538054871487499,0.6087591240875913,0.0962155227758276,"['VPS4A', 'HLA-B', 'MERTK']",0.9854814999105933,0,0,3
309,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.8538054871487499,0.6087591240875913,0.0962155227758276,"['PSMC5', 'CCNE1', 'STUB1']",0.9854814999105933,0,0,3
310,B Cell Receptor Signaling Pathway WP23,0.8723031114763237,0.5413022351797862,0.07395179687786728,"['CD81', 'PRKCD']",0.9854814999105933,0,0,2
311,Monoamine GPCRs WP58,0.8723031114763237,0.5413022351797862,0.07395179687786728,"['HTR2C', 'HTR5A']",0.9854814999105933,0,0,2
312,Neural Crest Differentiation WP2064,0.8723031114763237,0.5413022351797862,0.07395179687786728,"['LHX2', 'FGFR2']",0.9854814999105933,0,0,2
313,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8723031114763237,0.5413022351797862,0.07395179687786728,"['PCNA', 'TGFB1']",0.9854814999105933,0,0,2
314,Breast cancer pathway WP4262,0.8831091776397144,0.5895800106326422,0.07328859341692415,"['CDK6', 'KIT', 'BAX', 'FGF1']",0.9854814999105933,0,0,4
315,Calcium Regulation in the Cardiac Cell WP536,0.8831091776397144,0.5895800106326422,0.07328859341692415,"['RGS16', 'PRKCD', 'ATP1B2', 'PRKD1']",0.9854814999105933,0,0,4
316,Integrated breast cancer pathway WP1984,0.8831091776397144,0.5895800106326422,0.07328859341692415,"['ODC1', 'BAX', 'FAU', 'JAKMIP1']",0.9854814999105933,0,0,4
317,NRF2 pathway WP2884,0.9057481663696688,0.5783308931185944,0.057251273189826535,"['HSP90AA1', 'TGFB1', 'SLC39A11', 'SLC39A7', 'FTL']",0.9854814999105933,0,0,5
318,Statin inhibition of cholesterol production WP430,0.9090874520364093,0.40611353711790393,0.03870829859890821,['APOE'],0.9854814999105933,0,0,1
319,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.9090874520364093,0.40611353711790393,0.03870829859890821,['TGFB1'],0.9854814999105933,0,0,1
320,Folate Metabolism WP176,0.9090874520364093,0.40611353711790393,0.03870829859890821,['GPX4'],0.9854814999105933,0,0,1
321,Glycogen Synthesis and Degradation WP500,0.9090874520364093,0.40611353711790393,0.03870829859890821,['PHKG1'],0.9854814999105933,0,0,1
322,Mesodermal commitment pathway WP2857,0.9090874520364093,0.40611353711790393,0.03870829859890821,['RPL38'],0.9854814999105933,0,0,1
323,miRNA targets in ECM and membrane receptors WP2911,0.9090874520364093,0.40611353711790393,0.03870829859890821,['COL5A1'],0.9854814999105933,0,0,1
324,p38 MAPK Signaling Pathway WP400,0.9090874520364093,0.40611353711790393,0.03870829859890821,['DDIT3'],0.9854814999105933,0,0,1
325,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9090874520364093,0.40611353711790393,0.03870829859890821,['MAPK11'],0.9854814999105933,0,0,1
326,Wnt signaling pathway and pluripotency WP399,0.9128423929568448,0.46355685131195334,0.04227269434611901,"['PRKCD', 'PRKD1']",0.9854814999105933,0,0,2
327,Wnt signaling WP428,0.9128423929568448,0.46355685131195334,0.04227269434611901,"['SFRP1', 'ROR2']",0.9854814999105933,0,0,2
328,Development of ureteric collection system WP5053,0.9128423929568448,0.46355685131195334,0.04227269434611901,"['GDF11', 'FGFR2']",0.9854814999105933,0,0,2
329,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9128423929568448,0.46355685131195334,0.04227269434611901,"['MAPK11', 'TGFB1']",0.9854814999105933,0,0,2
330,G Protein Signaling Pathways WP35,0.9128423929568448,0.46355685131195334,0.04227269434611901,"['PRKCD', 'PRKD1']",0.9854814999105933,0,0,2
331,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9128423929568448,0.46355685131195334,0.04227269434611901,"['SFRP1', 'ROR2']",0.9854814999105933,0,0,2
332,Insulin Signaling WP481,0.9135346995728341,0.5399610136452242,0.04883079034657669,"['MAPK11', 'PRKCD', 'SGK1', 'PFKM']",0.9854814999105933,0,0,4
333,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9141095806970128,0.6321956841903055,0.056774221748281326,"['HSP90AA1', 'COL5A1', 'PIK3IP1', 'PDGFC', 'KIT', 'RPS6', 'VEGFB', 'FGF1', 'FGFR2']",0.9854814999105933,0,0,9
334,Regulation of Actin Cytoskeleton WP51,0.9247356281525914,0.48613138686131385,0.03803851208433687,"['TMSB4X', 'FGF1', 'FGFR2']",0.9878025047079195,0,0,3
335,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9437778805426641,0.3245997088791849,0.018782779261316336,['TMSB4X'],0.9878025047079195,0,0,1
336,Bladder cancer WP2828,0.9437778805426641,0.3245997088791849,0.018782779261316336,['CDKN2A'],0.9878025047079195,0,0,1
337,Chemokine signaling pathway WP3929,0.9437778805426641,0.3245997088791849,0.018782779261316336,['PRKCD'],0.9878025047079195,0,0,1
338,Unfolded protein response WP4925,0.9437778805426641,0.3245997088791849,0.018782779261316336,['DDIT3'],0.9878025047079195,0,0,1
339,DNA Replication WP466,0.9437778805426641,0.3245997088791849,0.018782779261316336,['PCNA'],0.9878025047079195,0,0,1
340,Genes controlling nephrogenesis WP4823,0.9437778805426641,0.3245997088791849,0.018782779261316336,['FGFR2'],0.9878025047079195,0,0,1
341,Male infertility WP4673,0.9437778805426641,0.3245997088791849,0.018782779261316336,['TEX15'],0.9878025047079195,0,0,1
342,MET in type 1 papillary renal cell carcinoma WP4205,0.9437778805426641,0.3245997088791849,0.018782779261316336,['RPL11'],0.9878025047079195,0,0,1
343,Phosphodiesterases in neuronal function WP4222,0.9437778805426641,0.3245997088791849,0.018782779261316336,['PDE3A'],0.9878025047079195,0,0,1
344,"GPCRs, Class A Rhodopsin-like WP455",0.9472245089473793,0.5051244509516838,0.027387413339512775,"['MC1R', 'P2RY14', 'HTR2C', 'HTR5A', 'MCHR1']",0.9885279032328755,0,0,5
345,ESC Pluripotency Pathways WP3931,0.9604475338117033,0.35989633948817623,0.014523948638669825,"['FGF1', 'FGFR2']",0.9935949497708777,0,0,2
346,Glucocorticoid Receptor Pathway WP2880,0.9652427669455003,0.2702571567200388,0.009560519158674022,['HSP90AA1'],0.9935949497708777,0,0,1
347,"GPCRs, Other WP117",0.9652427669455003,0.2702571567200388,0.009560519158674022,['ACKR1'],0.9935949497708777,0,0,1
348,Ciliopathies WP4803,0.9736337806918229,0.3236151603498542,0.00864701042605153,"['CCDC65', 'WDR34']",0.9935949497708777,0,0,2
349,Oncostatin M Signaling Pathway WP2374,0.9736337806918229,0.3236151603498542,0.00864701042605153,"['PRKCD', 'RPS6']",0.9935949497708777,0,0,2
350,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9785197205070616,0.2314410480349345,0.005025589267932138,['MAPK11'],0.9935949497708777,0,0,1
351,Nuclear Receptors Meta-Pathway WP2882,0.9808435466493186,0.4986542075059672,0.009645127093512972,"['PSMC5', 'HSP90AA1', 'TGFB1', 'SLC39A11', 'AIP', 'BAX', 'SLC39A7', 'CYP3A5', 'FTL']",0.9935949497708777,0,0,9
352,Adipogenesis WP236,0.9821235493223758,0.345985401459854,0.006240941609547441,"['WWTR1', 'TGFB1', 'DDIT3']",0.9935949497708777,0,0,3
353,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9825242539517036,0.2939305592366817,0.005182069120730718,"['RPS6', 'PRKCD']",0.9935949497708777,0,0,2
354,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9825242539517036,0.2939305592366817,0.005182069120730718,"['TGFB1', 'RUNX2']",0.9935949497708777,0,0,2
355,Endochondral Ossification WP474,0.9825242539517036,0.2939305592366817,0.005182069120730718,"['TGFB1', 'RUNX2']",0.9935949497708777,0,0,2
356,Circadian rhythm related genes WP3594,0.9950505588918706,0.2303206997084548,0.0011427891617147988,"['CRH', 'RPS27A']",0.9980718775752001,0,0,2
357,Focal Adhesion WP306,0.9967740858741457,0.21477162293488825,0.0006939547342254935,"['PDGFC', 'VEGFB']",0.9980718775752001,0,0,2
358,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.997903896939886,0.20116618075801748,0.00042210759229782056,"['ACOT2', 'TM7SF2']",0.9980718775752001,0,0,2
359,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9980718775752001,0.1344007763221737,0.00025939130026692356,['SST'],0.9980718775752001,0,0,1
